BlackRock Inc. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 87 filers reported holding CTI BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$8,000
+100.0%
14,306
+330.4%
0.00%
Q4 2015$4,000
-20.0%
3,3240.0%0.00%
Q3 2015$5,000
-16.7%
3,3240.0%0.00%
Q2 2015$6,000
-14.3%
3,324
-18.7%
0.00%
Q1 2015$7,000
-30.0%
4,0900.0%0.00%
Q4 2014$10,000
+25.0%
4,090
+18.3%
0.00%
Q3 2014$8,000
-20.0%
3,4580.0%0.00%
Q2 2014$10,0003,4580.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,425,000$3,363,0002.66%
ACUTA CAPITAL PARTNERS, LLC 1,228,111$2,898,0001.96%
Sio Capital Management, LLC 505,000$1,192,0000.94%
RA Capital Management 2,500,000$5,900,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 750,000$1,770,0000.30%
TFS CAPITAL LLC 1,295,744$3,058,0000.29%
EAGLE ASSET MANAGEMENT INC 12,713,051$30,002,0000.17%
JW Asset Management, LLC 52,271$123,0000.09%
Lombard Odier Asset Management (USA) Corp 501,444$1,183,0000.08%
First Heartland Consultants, Inc. 74,624$176,0000.07%
View complete list of CTI BIOPHARMA CORP shareholders